e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Savara, Inc. - Common Stock (NQ:SVRA)

5.240 +0.190 (+3.76%)

Streaming Delayed Price Updated: 9:30 AM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Savara, Inc. - Common Stock

< Previous 1 2 Next >

VR Adviser Adds Over 1 Million Savara Shares ↗

March 15, 2026

This clinical-stage biotech develops inhaled therapies for rare respiratory diseases, with its lead candidate in Phase III trials.

Via The Motley Fool

Topics Regulatory Compliance

SVRA Stock Rises After Hours As FDA Grants Priority Review For Lung Disorder Therapy ↗

February 20, 2026

The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).

Via Stocktwits

Topics Intellectual Property Lawsuit

Get insights into the top gainers and losers of Friday's after-hours session. ↗

February 20, 2026

Via Chartmill

SVRA Stock Earnings: Savara Misses EPS for Q2 2024 ↗

August 12, 2024

SVRA stock results show that Savara missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

SVRA Stock Earnings: Savara Misses EPS for Q1 2024 ↗

May 09, 2024

SVRA stock results show that Savara missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

SVRA Stock Earnings: Savara Beats EPS for Q4 2023 ↗

March 07, 2024

SVRA stock results show that Savara beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

What's going on in today's pre-market session ↗

January 02, 2026

Via Chartmill

This Starbucks Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

May 29, 2025

Via Benzinga

Why Is Rare Lung Disease-Focused Savara Stock Trading Lower On Tuesday? ↗

May 27, 2025

Savara's Molbreevi BLA for autoimmune PAP was rejected by the FDA due to incomplete CMC data; the company plans to resubmit in Q4 2025.

Via Benzinga

Here are the top movers in Tuesday's session. ↗

May 27, 2025

Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 27, 2025

Via Benzinga

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

May 27, 2025

Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.

Via Chartmill

Dow Surges Over 600 Points; US Durable Goods Orders Fall in April ↗

May 27, 2025

Via Benzinga

Topics Stocks

There are notable gap-ups and gap-downs in today's session. ↗

May 27, 2025

In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Nasdaq Jumps Over 300 Points On EU Tariff Delay; AutoZone Posts Downbeat Earnings ↗

May 27, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

May 27, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 18, 2025

Via Benzinga

Why Summit Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

September 09, 2024

Via Benzinga

Why Is Respiratory Disease-Focused Savara Stock Trading Higher On Wednesday? ↗

June 26, 2024

Savara announces Phase 3 IMPALA-2 trial results for molgramostim in treating autoimmune pulmonary alveolar proteinosis. The inhaled GM-CSF met primary and secondary endpoints, showing significant...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 26, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!

Via InvestorPlace

3 Penny Stocks Poised for Major Upside Over the Next 5 Years ↗

June 19, 2024

These three penny stocks to buy are poised for major upside over the medium-term, for various reasons worth exploring.

Via InvestorPlace

3 Penny Stocks That Can Deliver Over 5,000% Upside by 2025: June Edition ↗

June 11, 2024

Don’t miss out on these three penny stocks, which have amazing potential to take off following upcoming business developments this year.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 16, 2024

Via Benzinga

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday ↗

January 02, 2024

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Via Benzinga

Topics Stocks

5 OTC Stocks With The Potential To Explode In 2024 ↗

November 08, 2023

Investors who are ready to dive into the OTC pool have more options than ever, both with the number of stocks to choose from and available investing platforms.

Via Benzinga

3 Penny Stocks to Provide 1,000% Returns Over the Next Decade ↗

September 27, 2023

Consider three intriguing penny stocks for investors looking to add a bit more risk to their portfolio in times like these.

Via InvestorPlace

The 3 Best Penny Stocks to Buy Now: September 2023 ↗

September 12, 2023

When all the focus lies on the largest names of the economy, these best penny stocks to buy offer a great risk/reward ratio.

Via InvestorPlace

Topics Economy

Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday ↗

July 20, 2023

U.S. stocks traded mixed, with the Dow Jones gaining over 200 points on Thursday. Here are some big stocks recording gains in today’s session. Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) shares rose...

Via Benzinga

Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday ↗

June 30, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy